Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
NORTH CHICAGO, Ill. , May 29, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Goldman Sachs 39 th Annual Global Healthcare Conference on Tuesday, June 12, 2018 . Richard A. Gonzalez , chairman and chief executive officer, will
Toggle Summary AbbVie to Present at the Jefferies 2018 Global Healthcare Conference
NORTH CHICAGO, Ill. , May 22, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Jefferies 2018 Global Healthcare Conference on Wednesday, June 6, 2018 . Bill Chase , executive vice president and chief financial officer, will present
Toggle Summary AbbVie to Present at the UBS Global Healthcare Conference
NORTH CHICAGO, Ill. , May 8, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the UBS Global Healthcare Conference on Tuesday, May 22, 2018 . Bill Chase , executive vice president and chief financial officer, will present at 7:30 a.m.
Toggle Summary AbbVie to Present at the 2018 Bank of America Merrill Lynch Health Care Conference
NORTH CHICAGO, Ill. , May 2, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the 2018 Bank of America Merrill Lynch Health Care Conference on Wednesday, May 16, 2018 . Richard A. Gonzalez , chairman and chief executive officer, will
Toggle Summary AbbVie Commences Self-Tender Offer for Up to $7.5 Billion of its Common Stock
NORTH CHICAGO, Ill. , May 1, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) announced today that it has commenced a modified "Dutch auction" tender offer to purchase for cash up to $7.5 billion of its common stock at a price not less than $99.00 per share and not more than $114.00 per share.
Toggle Summary AbbVie Reports First-Quarter 2018 Financial Results
- Reports First-Quarter Diluted EPS of $1.74 on a GAAP Basis; Adjusted Diluted EPS of $1.87 Reflects Growth of 46.1 Percent - Delivers First-Quarter Net Revenues of $7.934 Billion; Net Revenues Increased 17.6 Percent on an Operational Basis - First-Quarter Global HUMIRA Sales of $4.709 Billion
Toggle Summary AbbVie to Present at the Deutsche Bank's 43rd Annual Health Care Conference
NORTH CHICAGO, Ill. , April 18, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Deutsche Bank's 43 rd Annual Health Care Conference on Wednesday, May 9, 2018 . Bill Chase , executive vice president and chief financial officer,
Toggle Summary AbbVie to Host First-Quarter 2018 Earnings Conference Call
NORTH CHICAGO, Ill. , April 6, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2018 financial results on Thursday, Apr. 26, 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie to Present at the Barclays Global Healthcare Conference
NORTH CHICAGO, Ill. , Feb. 26, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Barclays Global Healthcare Conference on Thursday, March 15, 2018 . Bill Chase , executive vice president and chief financial officer, will present at 8 a.m. Central time .
Toggle Summary AbbVie to Present at the Cowen and Company 38th Annual Health Care Conference
NORTH CHICAGO, Ill. , Feb. 22, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018 . Bill Chase , executive vice president and chief financial officer will present at 7:00 a.m. Central time .